
CAS 1263774-59-9: Etrasimod arginine
Description:Etrasimod arginine, identified by its CAS number 1263774-59-9, is a small molecule that functions primarily as a selective modulator of the sphingosine-1-phosphate (S1P) receptor. This compound is notable for its potential therapeutic applications, particularly in the treatment of autoimmune diseases and inflammatory conditions. Etrasimod arginine exhibits a favorable pharmacokinetic profile, which includes good oral bioavailability and a manageable half-life, allowing for convenient dosing regimens. The compound's mechanism of action involves the modulation of lymphocyte trafficking, leading to a reduction in the migration of immune cells to sites of inflammation. This characteristic makes it a candidate for therapies aimed at conditions such as ulcerative colitis and multiple sclerosis. Additionally, its safety profile has been evaluated in clinical trials, showing a generally tolerable side effect profile. Overall, Etrasimod arginine represents a promising avenue in the development of targeted therapies for chronic inflammatory diseases.
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | Delgocitinib REF: TM-T15096CAS: 1263774-59-9 | 99.90% | 169.00 €~2,775.00 € | Mon 14 Apr 25 |
![]() | Delgocitinib REF: 54-BUP12494CAS: 1263774-59-9 | 99.9% | 1,257.00 €~5,105.00 € | Tue 15 Apr 25 |
![]() | Delgocitinib REF: 3D-BD178539CAS: 1263774-59-9 | Min. 95% | 500.00 €~2,630.00 € | Tue 27 May 25 |

Delgocitinib
Ref: TM-T15096
1mg | 169.00 € | ||
5mg | 311.00 € | ||
10mg | 487.00 € | ||
25mg | 929.00 € | ||
50mg | 1,415.00 € | ||
100mg | 2,062.00 € | ||
200mg | 2,775.00 € | ||
1mL*10mM (DMSO) | 349.00 € |

Ref: 54-BUP12494
25mg | 1,257.00 € | ||
50mg | 1,917.00 € | ||
100mg | 2,791.00 € | ||
200mg | 3,755.00 € | ||
500mg | 5,105.00 € |

Delgocitinib
Ref: 3D-BD178539
1mg | 500.00 € | ||
5mg | 1,688.00 € | ||
10mg | 2,630.00 € |